Matrix metalloproteinase-2 predicts cardiac mortality and heart failure hospitalization after acute myocardial infarction

被引：0
|
作者：
Yajima, K. [1 ]
Ohte, N. [2 ]
Tanaka, S. [1 ]
Kawamiya, T. [1 ]
Fujimaki, T. [1 ]
Kato, K. [1 ]
Hibino, T. [1 ]
Yokoi, K. [1 ]
Kimura, G. [2 ]
机构：
[1] Gifu Prefectural Tajimi Hosp, Tajimi, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [41] Hospital volume and 30-day mortality following hospitalization for acute myocardial infarction and heart failure
    Ross, Joseph S.
    Wang, Yun
    Normand, Sharon-Lise T.
    Ko, Dennis T.
    Chen, Jersey
    Lichtman, Judith H.
    Krumholz, Harlan M.
    CIRCULATION, 2008, 117 (21) : E411 - E411
  • [42] Predictors of Long-Term Risk for Heart Failure Hospitalization after Acute Myocardial Infarction
    Perkiomaki, Juha S.
    Hamekoski, Sari
    Junttila, M. Juhani
    Jokinen, Vesa
    Tapanainen, Jari
    Huikuri, Heikki V.
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2010, 15 (03) : 250 - 258
  • [43] Incidence, Predictors, and Implications of Re-Hospitalization for Heart Failure after Acute Myocardial Infarction
    Song, Pil-Sang
    Jeong, Myung Ho
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S151 - S151
  • [44] Matrix metalloproteinase-2 and-9 in the pathogenesis of left ventricular remodelling post acute myocardial infarction in humans
    Kelly, D.
    Khan, S.
    Samani, N.
    Thompson, M.
    Ng, L.
    Squire, I.
    HEART, 2006, 92 : A60 - A60
  • [45] D-dimer and the incidence of heart failure and mortality after acute myocardial infarction
    Zhang, Xiaoyuan
    Wang, Shanjie
    Liu, Jinxin
    Wang, Yini
    Cai, Hengxuan
    Wang, Duolao
    Fang, Shaohong
    Yu, Bo
    HEART, 2021, 107 (03) : 237 - 244
  • [46] CONGESTIVE HEART FAILURE AFTER ACUTE MYOCARDIAL INFARCTION
    SCHEINMA.MM
    SLEISENG.MH
    CALIFORNIA MEDICINE, 1971, 114 (02): : 23 - +
  • [47] Levosimendan Use Reduces Matrix Metalloproteinase-2 in Patients with Decompensated Heart Failure
    Dimitrios N. Tziakas
    Georgios K. Chalikias
    Helen I. Hatzinikolaou
    Dimitrios A. Stakos
    Nikolaos Papanas
    Ioannis K. Tentes
    Alexandros X. Kortsaris
    Efstratios Maltezos
    Dimitrios I. Hatseras
    Juan Carlos Kaski
    Cardiovascular Drugs and Therapy, 2005, 19 : 399 - 402
  • [48] The Role of Matrix Metalloproteinase-2 Promoter Polymorphisms in Coronary Artery Disease and Myocardial Infarction
    Alp, Ebru
    Menevse, Sevda
    Tulmac, Murat
    Yilmaz, Akin
    Yalcin, Ridvan
    Cengel, Atiye
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2011, 15 (04) : 193 - 202
  • [49] Elevated plasma microRNA-1 predicts heart failure after acute myocardial infarction
    Zhang, Rong
    Niu, Huifang
    Ban, Tao
    Xu, Ling
    Li, Yue
    Wang, Ning
    Sun, Lihua
    Ai, Jing
    Yang, Baofeng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (01) : 259 - 260
  • [50] Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure
    Tziakas, DN
    Chalikias, GK
    Hatzinikolaou, HI
    Stakos, DA
    Papanas, N
    Tentes, IK
    Kortsaris, AX
    Maltezos, E
    Hatseras, DI
    Kaski, JC
    CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (06) : 399 - 402
12345